Anaemia of chronic disease (anaemia of inflammation; anaemia of chronic disorders, ACD)
Anaemia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Hepcidin-driven iron sequestration and blunted erythropoiesis from chronic infection, inflammation, malignancy or CKD. Usually mild-moderate normocytic (sometimes microcytic) anaemia with LOW serum iron but NORMAL/HIGH ferritin. Treat the underlying disease; iron and ESAs only in selected cases.
Red flags
- Rapidly worsening anaemia (suggests bleeding or marrow process, not ACD)
- Very low MCV / very high ferritin discordant with picture - reconsider diagnosis
- Weight loss, night sweats, lymphadenopathy (occult malignancy)
- New anaemia with renal failure and bone pain (myeloma)
Assessment
Differential diagnosis
- Iron-deficiency anaemia (ferritin low, TIBC high)
- Combined ACD + iron deficiency
- Anaemia of CKD (EPO deficiency)
- Thalassaemia trait
- Myelodysplasia, marrow infiltration
- Haemolysis, B12/folate deficiency
Investigations
- FBC + MCV + reticulocytes (low/normal retic, normocytic or mildly microcytic)
- Iron studies: serum iron low, TIBC/transferrin low-normal, transferrin saturation low, ferritin normal or high (acute phase)
- CRP/ESR (inflammation), renal function
- Blood film; exclude bleeding (coeliac screen, FIT/endoscopy if iron deficiency suspected)
- Identify underlying disorder: infection screen, autoimmune/malignancy workup as indicated
- Consider soluble transferrin receptor or sTfR/log ferritin index if coexisting iron deficiency unclear
Management
- Confirm the pattern (low iron, non-low ferritin) and exclude concurrent true iron deficiency / blood loss
- Direct treatment at the underlying condition - this is the definitive therapy
- Reserve blood transfusion for symptomatic/severe anaemia or cardiovascular compromise; use restrictive thresholds
- In CKD or chemotherapy-related anaemia, consider erythropoiesis-stimulating agents under specialist guidance (ensure iron replete, caution re: thrombosis/BP/tumour outcomes)
- Give iron (preferably IV) only if coexisting absolute/functional iron deficiency demonstrated
- Avoid reflex long-term oral iron when ferritin is high - ineffective due to hepcidin block
Drugs & doses
Treat underlying cause (antimicrobials, immunosuppression, cancer therapy) - no specific anaemia drug for pure ACD
IV iron (e.g. ferric carboxymaltose 1000 mg IV, dose by weight/Hb deficit) only if functional/absolute iron deficiency coexists [verify local dose]
Erythropoiesis-stimulating agent (e.g. epoetin / darbepoetin) in CKD or chemo-anaemia per specialist protocol, target Hb ~100-120 g/L, avoid overshoot [verify local dose]
Transfuse packed red cells only for symptomatic severe anaemia (restrictive threshold, typically Hb <70 g/L or <80 if cardiac disease)
Disposition
Usually outpatient - investigate and treat the underlying cause via GP/relevant specialty. Admit only for severe symptomatic anaemia or the underlying illness.
Complications & pitfalls
- Symptomatic anaemia impairing cardiac/functional status
- Masked coexisting iron deficiency
- ESA-related thrombosis / hypertension / worse tumour outcomes if overtreated
Exam pearls
- Ferritin is an acute-phase reactant - a 'normal' ferritin in inflammation does NOT exclude iron deficiency; transferrin saturation and sTfR help
- ACD anaemia is usually mild (Hb 80-110 g/L) - severe anaemia warrants a second diagnosis
- Treat the disease, not the number - routine iron/ESAs are not first-line for pure ACD
- Oral iron is poorly absorbed when hepcidin is high; IV iron preferred if truly deficient
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.